Success Metrics

Clinical Success Rate
100.0%

Based on 12 completed trials

Completion Rate
100%(12/12)
Active Trials
0(0%)
Results Posted
42%(5 trials)

Phase Distribution

Ph phase_1
7
58%
Ph phase_2
5
42%

Phase Distribution

7

Early Stage

5

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
7(58.3%)
Phase 2Efficacy & side effects
5(41.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

12 of 12 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(12)

Detailed Status

Completed12

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 17 (58.3%)
Phase 25 (41.7%)

Trials by Status

completed12100%

Recent Activity

Clinical Trials (12)

Showing 12 of 12 trials

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12